1. Home
  2. OSBC vs ABVX Comparison

OSBC vs ABVX Comparison

Compare OSBC & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OSBC
  • ABVX
  • Stock Information
  • Founded
  • OSBC 1981
  • ABVX 2013
  • Country
  • OSBC United States
  • ABVX France
  • Employees
  • OSBC N/A
  • ABVX N/A
  • Industry
  • OSBC Major Banks
  • ABVX
  • Sector
  • OSBC Finance
  • ABVX
  • Exchange
  • OSBC Nasdaq
  • ABVX Nasdaq
  • Market Cap
  • OSBC 838.3M
  • ABVX 722.3M
  • IPO Year
  • OSBC N/A
  • ABVX N/A
  • Fundamental
  • Price
  • OSBC $18.20
  • ABVX $6.16
  • Analyst Decision
  • OSBC Buy
  • ABVX Strong Buy
  • Analyst Count
  • OSBC 4
  • ABVX 7
  • Target Price
  • OSBC $18.75
  • ABVX $37.86
  • AVG Volume (30 Days)
  • OSBC 266.3K
  • ABVX 216.6K
  • Earning Date
  • OSBC 01-22-2025
  • ABVX 09-09-2024
  • Dividend Yield
  • OSBC 1.32%
  • ABVX N/A
  • EPS Growth
  • OSBC N/A
  • ABVX N/A
  • EPS
  • OSBC 1.85
  • ABVX N/A
  • Revenue
  • OSBC $264,069,000.00
  • ABVX $9,676,417.00
  • Revenue This Year
  • OSBC N/A
  • ABVX $31.67
  • Revenue Next Year
  • OSBC N/A
  • ABVX $759.77
  • P/E Ratio
  • OSBC $9.84
  • ABVX N/A
  • Revenue Growth
  • OSBC N/A
  • ABVX 100.87
  • 52 Week Low
  • OSBC $13.00
  • ABVX $5.54
  • 52 Week High
  • OSBC $19.37
  • ABVX $17.02
  • Technical
  • Relative Strength Index (RSI)
  • OSBC 55.44
  • ABVX 30.30
  • Support Level
  • OSBC $16.92
  • ABVX $5.54
  • Resistance Level
  • OSBC $18.52
  • ABVX $6.46
  • Average True Range (ATR)
  • OSBC 0.52
  • ABVX 0.51
  • MACD
  • OSBC 0.07
  • ABVX -0.04
  • Stochastic Oscillator
  • OSBC 80.00
  • ABVX 30.10

About OSBC Old Second Bancorp Inc.

Old Second Bancorp Inc is a bank holding company. It provides consumer and commercial banking products such as demand, money market, savings, time deposit, and individual retirement as well as commercial, industrial, consumer, and real estate lending, including installment loans, student loans, agricultural loans, lines of credit and overdraft checking, safe deposit operations, trust services, wealth management services, and additional services tailored to the needs of individual customers, corporates, small-medium enterprises. The company's revenue consists of interest, commission, payments, and other income.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. They are evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two most common forms are UC and CD.

Share on Social Networks: